Reinhardt U, Wolf H, Müller C
Z Gesamte Inn Med. 1987 Mar 1;42(5):134-7.
In 41 female patients with metastasizing carcinoma of the breast remission rate and survival time were analysed under a combined chemotherapy and hormone therapy as well as marginal conditions of the treatment, such as referral modalities and periods. The remission frequency of 66% in an average duration of the remission of 9.6 months corresponds to the international experiences. In only 5% of all patients a specialist in internal medicine and oncology took part in the statement of the primary therapy conception. In many cases the referral to the medicamentous therapy was done only in the late stages of the disease. An improvement of the interdisciplinary cooperation in the treatment of the carcinoma of the breast is actually necessary.
对41例转移性乳腺癌女性患者在联合化疗和激素治疗以及治疗的边缘条件（如转诊方式和时间）下的缓解率和生存时间进行了分析。缓解频率为66%，平均缓解持续时间为9.6个月，这与国际经验相符。在所有患者中，仅有5%的患者有内科和肿瘤学专家参与了初始治疗方案的制定。在许多情况下，直到疾病晚期才开始药物治疗。实际上，有必要改善乳腺癌治疗中的多学科合作。
